Search results for "Therapeutics."

showing 10 items of 480 documents

Beta-Lactam Sensitive Bacteria Can Acquire ESBL-Resistance via Conjugation after Long-Term Exposure to Lethal Antibiotic Concentration

2020

Beta-lactams are commonly used antibiotics that prevent cell-wall biosynthesis. Beta-lactam sensitive bacteria can acquire conjugative resistance elements and hence become resistant even after being exposed to lethal (above minimum inhibitory) antibiotic concentrations. Here we show that neither the length of antibiotic exposure (1 to 16 h) nor the beta-lactam type (penam or cephem) have a major impact on the rescue of sensitive bacteria. We demonstrate that an evolutionary rescue can occur between different clinically relevant bacterial species (Klebsiella pneumoniae and Escherichia coli) by plasmids that are commonly associated with extended-spectrum beta-lactamase (ESBL) positive hospita…

Microbiology (medical)antibiotic resistancemedicine.drug_classKlebsiella pneumoniaeAntibioticsextended-spectrum beta-lactamaseBiologymedicine.disease_causeBiochemistryMicrobiologyArticleMicrobiologybakteerit03 medical and health sciencesplasmiditPlasmidAntibiotic resistancemedicineCRISPRPharmacology (medical)Klebsiella-bakteeritGeneral Pharmacology Toxicology and PharmaceuticsEscherichia coli030304 developmental biology0303 health sciencesCephemconjugative plasmid.030306 microbiologylcsh:RM1-950antibiootitbiology.organism_classification3. Good healthExtended-spectrum beta-lactamaseInfectious Diseaseslcsh:Therapeutics. Pharmacologyconjugative plasmidevolutionary rescuehorisontaalinen geeninsiirtoBacteriakolibakteeritantibioottiresistenssi
researchProduct

Antibiotics and Environment.

2020

Since the discovery of penicillin by Alexander Fleming in 1928, the use of antibiotics has become the golden standard in the treatment of bacterial infections of all kinds [...]

Microbiology (medical)endocrine systemmedicine.medical_specialtymedicine.drug_classbusiness.industryanimal diseaseslcsh:RM1-950AntibioticsBiochemistryMicrobiologyAntibiotics antibiotic resistance environmentPenicillinn/alcsh:Therapeutics. PharmacologyInfectious DiseasesAntibiotic resistanceEditorialmedicinePharmacology (medical)General Pharmacology Toxicology and PharmaceuticsIntensive care medicinebusinesshuman activitiesmedicine.drugAntibiotics (Basel, Switzerland)
researchProduct

Gelation behavior of 5-chloro-8-hydroxyquinoline, an antituberculosis agent, in aqueous alcohol solutions

2012

It was shown that 5-chloro-8-hydroxyquinoline, an antituberculosis agent, gels aqueous alcohol solutions efficiently. Thermal stability and gel-to-sol transition temperature of 1% gel in CD3OD/D2O (2:1) was studied by 1H-NMR. Fibrous structures of four xerogels have been characterized by scanning electron microscope. peerReviewed

Microbiology (medical)gelScanning electron microscope5-kloori-8-hydroksikinoliinigel; 5-chloro-8-hydroxyquinoline; <em>Mycobacterium </em><em>tuberculosis</em>gelationBiochemistryMicrobiologyArticle5-chloro-8-hydroxyquinolinechemistry.chemical_compoundOrganic chemistryPharmacology (medical)Thermal stabilityGeneral Pharmacology Toxicology and Pharmaceuticsta116Aqueous alcoholgeelin muodostusTransition temperature5-chloro-8-hydoxyquinolinelcsh:RM1-950Antituberculosis agent8-HydroxyquinolineMycobacterium tuberculosisInfectious Diseaseslcsh:Therapeutics. PharmacologychemistryNuclear chemistryAntibiotics
researchProduct

Intervención cognitivo conductual para mujeres con trastorno depresivo persistente: sintomatología ansiosa, depresiva y satisfacción vital

2021

Antecedentes. El trastorno depresivo persistente (TDP) es una afectación del estado de ánimo frecuente en mujeres. Se ha empleado la terapia cognitivo conductual (TCC), la terapia cognitiva basada en mindfulness y la terapia centrada en la compasión de forma aislada. Objetivos. Evaluar la eficacia de un programa de intervención grupal multicomponente. Método. Tras la firma del consentimiento informado, las participantes (n = 6) respondieron (pre, post intervención y seguimiento) cuestionarios sobre: ansiedad, depresión, satisfacción con la vida y satisfacción con la intervención. Resultados. Nuestros resultados previos al tratamiento muestran niveles elevados de sintomatología ansiosa y dep…

Microbiology (medical)gender perspectivelcsh:Therapeutics. Psychotherapylcsh:RC475-489lcsh:PsychologyPsicologiaImmunologylcsh:BF1-990Immunology and Allergypersistent depressive disorderlife satisfactioncognitive behavioral therapy
researchProduct

Treatment of Pulmonary Disease of Cystic Fibrosis: A Comprehensive Review.

2021

Cystic fibrosis (CF) is a genetic disease that causes absence or dysfunction of a protein named transmembrane conductance regulatory protein (CFTR) that works as an anion channel. As a result, the secretions of the organs where CFTR is expressed are very viscous, so their functionality is altered. The main cause of morbidity is due to the involvement of the respiratory system as a result of recurrent respiratory infections by different pathogens. In recent decades, survival has been increasing, rising by around age 50. This is due to the monitoring of patients in multidisciplinary units, early diagnosis with neonatal screening, and advances in treatments. In this chapter, we will approach t…

Microbiology (medical)medicine.drug_classAntibioticsRNA therapyInflammationDiseaseRM1-950ReviewBioinformaticsBiochemistryMicrobiologyCystic fibrosiscystic fibrosis03 medical and health sciences0302 clinical medicineantibioticmedicinePharmacology (medical)030212 general & internal medicineGeneral Pharmacology Toxicology and PharmaceuticsRespiratory systemGeneCFTR modulatorRegulation of gene expressiontreatmentbusiness.industrymedicine.diseaseobstructionTransmembrane proteinInfectious Diseases030228 respiratory systeminflammationediting geneTherapeutics. Pharmacologymedicine.symptombusinessgenetic therapyAntibiotics (Basel, Switzerland)
researchProduct

Colonization Resistance of the Gut Microbiota against Clostridium difficile

2015

Antibiotics strongly disrupt the human gut microbiota, which in consequence loses its colonization resistance capacity, allowing infection by opportunistic pathogens such as Clostridium difficile. This bacterium is the main cause of antibiotic-associated diarrhea and a current problem in developed countries, since its incidence and severity have increased during the last years. Furthermore, the emergence of antibiotic resistance strains has reduced the efficiency of the standard treatment with antibiotics, leading to a higher rate of relapses. Here, we review recent efforts focused on the impact of antibiotics in the gut microbiome and their relationship with C. difficile colonization, as w…

Microbiology (medical)medicine.drug_classAntibioticsReviewColonisation resistanceBiologyGut floradigestive systemBiochemistryMicrobiologyantibioticsMicrobiologyAntibiotic resistancecolonization resistancemedicinePharmacology (medical)ColonizationGeneral Pharmacology Toxicology and PharmaceuticsPathogenlcsh:RM1-950Clostridium difficileClostridium difficileAntimicrobialbiology.organism_classificationlcsh:Therapeutics. PharmacologyInfectious Diseasesgut microbiota restorationAntibiotics
researchProduct

The Role of Statins on Helicobacter pylori Eradication: Results from the European Registry on the Management of H. pylori (Hp-EuReg)

2021

Statins could increase the effectiveness of Helicobacter pylori eradication therapies due to their anti-inflammatory effect. The aim of this study was to analyze the impact of this therapeutic association in real life. This is a multicenter, prospective, non-interventional study aimed at evaluating the management of H. pylori by European gastroenterologists. Patients were registered in an e-CRF by AEG-REDCap from 2013 to 2020. The association between statin use and H. pylori eradication effectiveness was evaluated through multivariate analysis. Overall, 9988 and 705 patients received empirical and culture-guided treatment, respectively. Overall, statin use was associated with higher effecti…

Microbiology (medical)medicine.medical_specialtyMultivariate analysisHelicobacter pylori statins treatmentRM1-950BiochemistryMicrobiologyArticlestatinsRescue therapyInternal medicineIn real lifeMedicinePharmacology (medical)General Pharmacology Toxicology and Pharmaceuticsstatins ; Helicobacter pylori ; treatmentbiologyHelicobacter pyloritreatmentbusiness.industry<i>Helicobacter pylori</i>StatinStatin treatmentHelicobacter pyloribiology.organism_classificationTreatmentInfectious DiseasesTherapeutics. Pharmacologybusiness
researchProduct

Role of D-Mannose in the Prevention of Recurrent Uncomplicated Cystitis: State of the Art and Future Perspectives

2021

Background: Urinary tract infections (UTI) are highly frequent in women, with a significant impact on healthcare resources. Although antibiotics still represent the standard treatment to manage recurrent UTI (rUTI), D-mannose, an inert monosaccharide that is metabolized and excreted in urine and acts by inhibiting bacterial adhesion to the urothelium, represents a promising nonantibiotic prevention strategy. The aim of this narrative review is to critically analyze clinical studies reporting data concerning the efficacy and safety of D-mannose in the management of rUTIs. Methods: A non-systematic literature search, using the Pubmed, EMBASE, Scopus, Web of science, Cochrane Central Register …

Microbiology (medical)medicine.medical_specialtymedicine.drug_classUTIAntibiotics030232 urology & nephrologyReviewPlaceboBiochemistryMicrobiologylaw.invention03 medical and health sciences0302 clinical medicineRandomized controlled trialpreventionlawInternal medicineMedicinePharmacology (medical)General Pharmacology Toxicology and PharmaceuticsMedical prescriptionProspective cohort studyAdverse effectcystitistreatmentbusiness.industryStandard treatmentlcsh:RM1-950Infectious DiseasesSystematic reviewlcsh:Therapeutics. Pharmacologyfemale030220 oncology & carcinogenesiscystitis; d-mannose; female; prevention; treatment; urinary tract infections; utiurinary tract infectionsbusinessD-mannoseAntibiotics
researchProduct

Adapting a Phage to Combat Phage Resistance

2020

Phage therapy is becoming a widely recognized alternative for fighting pathogenic bacteria due to increasing antibiotic resistance problems. However, one of the common concerns related to the use of phages is the evolution of bacterial resistance against the phages, putatively disabling the treatment. Experimental adaptation of the phage (phage training) to infect a resistant host has been used to combat this problem. Yet, there is very little information on the trade-offs of phage infectivity and host range. Here we co-cultured a myophage FCV-1 with its host, the fish pathogen Flavobacterium columnare, in lake water and monitored the interaction for a one-month period. Phage resistance was…

Microbiology (medical)phage therapyGLIDING MOTILITYPhage therapyvirusesmedicine.medical_treatmentevoluutioVirulencefish pathogenmedicine.disease_causeBiochemistryMicrobiologyGenomebakteriofagitArticleMicrobiologyBacteriophage03 medical and health sciencesAntibiotic resistancemedicineCRISPRPharmacology (medical)General Pharmacology Toxicology and Pharmaceutics030304 developmental biology11832 Microbiology and virologyInfectivitylääkeresistenssi0303 health sciencesPREDATIONPRODUCTIVITYbiology030306 microbiologylcsh:RM1-950ARMS-RACEPathogenic bacteriakalatauditbiology.organism_classificationEVOLUTIONfagiterapialcsh:Therapeutics. PharmacologyInfectious Diseasesphage resistancecoevolution1182 Biochemistry cell and molecular biologyVIRULENCEHOST-RANGEBACTERIOPHAGEAntibiotics
researchProduct

Does Empagliflozin Modulate Leukocyte–Endothelium Interactions, Oxidative Stress, and Inflammation in Type 2 Diabetes?

2021

Sodium-glucose co-transporter 2 inhibitors (iSGLT2) have been linked to cardiovascular risk reduction in patients with type 2 diabetes (T2D). However, their underlying molecular mechanisms remain unclear. This study aimed to evaluate the effects of empagliflozin, a novel potent and selective iSGLT-2, on anthropometric and endocrine parameters, leukocyte–endothelium interactions, adhesion molecules, ROS production, and NFkB-p65 transcription factor expression. According to standard clinical protocols, sixteen T2D patients receiving 10 mg/day of empagliflozin were followed-up for 24 weeks. Anthropometric and analytical measurements were performed at baseline, 12 weeks, and 24 weeks. Interacti…

Mitochondrial ROScardiovascular riskGPX1medicine.medical_specialtyEndotheliumPhysiologyClinical Biochemistryempagliflozin030209 endocrinology & metabolismLeukocyte RollingInflammationRM1-950030204 cardiovascular system & hematologymedicine.disease_causeBiochemistry03 medical and health sciences0302 clinical medicineInternal medicineEmpagliflozinmedicineoxidative stressMolecular Biologybusiness.industryCell adhesion moleculeCommunicationCell Biologymedicine.anatomical_structureEndocrinologyinflammationtype 2 diabetesTherapeutics. Pharmacologymedicine.symptombusinessOxidative stressAntioxidants
researchProduct